The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level-Reference-Cited by-同舟云学术

The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level

Published:2016-03-28 Issue:18 Volume:7 Page:26551-26566
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Thongon Natthakan¹,Castiglioni Ilaria²,Zucal Chiara¹,Latorre Elisa¹,D’Agostino Vito¹,Bauer Inga³,Pancher Michael⁴,Ballestrero Alberto³,Feldmann Georg⁵,Nencioni Alessio³,Provenzani Alessandro¹

Affiliation:

1. Laboratory of Genomic Screening, Centre for Integrative Biology, University of Trento, Trento, Italy

2. Laboratory of Gene Expression and Muscular Dystrophy, San Raffaele Scientific Institute, Milan, Italy

3. Department of Internal Medicine, University of Genoa, Genoa, Italy

4. High Throughput Screening Facility, Centre for Integrative Biology, University of Trento, Trento, Italy

5. Laboratory of Pancreatic Cancer Translational Research, Clinic University of Bonn, Bonn, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: RNA recognition landscapes and anticancer drug targeting;Frontiers in Oncology;2023-06-19

2. The investigation of hippo signaling pathway in mouse uterus during peri-implantation period;Archives of Gynecology and Obstetrics;2022-06-16

3. PRDX2 Knockdown Inhibits Extracellular Matrix Synthesis of Chondrocytes by Inhibiting Wnt5a/YAP1/CTGF and Activating IL-6/JAK2/STAT3 Pathways in Deer Antler;International Journal of Molecular Sciences;2022-05-07

4. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma;Frontiers in Oncology;2021-07-29

5. N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression;Oncogene;2021-07-26